Improving human quality of life with drug treatments is a complicated issue. Drug certification, including drug safety and reliability, entails a long series of tests and government approvals before the drug is available for anyone to use.
Numinus to Present at the Small Cap Growth Virtual Investor Conference on July 13, 2023 | Psychedelic Invest
Numinus Wellness Inc. (TSX: NUMI / OTCQX: NUMIF) – a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that Payton Nyquvest,